Autori: Milisavljevic Slobodan S
Naslov | Hyperfractionated radiotherapy and concurrent low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II study. (Meeting Abstract) |
Autori | Jeremic Branislav Milicic Biljana R Acimovic Ljubisa Milisavljevic Slobodan S |
Info | JOURNAL OF CLINICAL ONCOLOGY, (2004), vol. 22 br. 14, Suppl. Suppl. S, str. 7164- |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Stage III non-small-cell lung cancer treated with high-dose hyperfractionated radiation therapy and concurrent low-dose daily chemotherapy with or without weekend chemotherapy - Retrospective analysis of 301 patients (Article) |
Autori | Jeremic Branislav Milicic Biljana R Dagovic Aleksandar Aleksandrovic Jasna Milisavljevic Slobodan S |
Info | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, (2004), vol. 27 br. 4, str. 350-360 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Radiotherapy and concurrent daily carboplatin/paclitaxel in stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II trial (Meeting Abstract) |
Autori | Jeremic Branislav Milicic Biljana R Acimovic Ljubisa Milisavljevic Slobodan S Radosavljevic-Asic Gordana D |
Info | STRAHLENTHERAPIE UND ONKOLOGIE, (2004), vol. 180 br. , Suppl. Suppl. 1, str. 33-33 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy alone (Article) |
Autori | Jeremic Branislav Shibamoto Y Milicic Biljana R Dagovic Aleksandar Nikolic Nebojsa Aleksandrovic Jasna Acimovic Ljubisa Milisavljevic Slobodan S |
Info | LUNG CANCER, (2003), vol. 40 br. 3, str. 317-323 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial (Article) |
Autori | Jeremic Branislav Shibamoto Y Acimovic Ljubisa Milicic Biljana R Milisavljevic Slobodan S Nikolic Nebojsa Dagovic Aleksandar Aleksandrovic Jasna Radosavljevic-Asic Gordana D |
Info | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, (2001), vol. 50 br. 1, str. 19-25 |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
|